Metabolic changes following subthalamotomy for advanced Parkinson's disease
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
We studied 6 advanced‐stage Parkinson's disease patients with [18 F] fluorodeoxyglucose/positron emission tomography before and 3 months after unilateral ablation of the subthalamic nucleus performed with microelectrode mapping. Operative changes in glucose metabolism were assessed by comparing baseline and postoperative scans. We also quantified operative changes in the activity of an abnormal Parkinson's disease‐related metabolic network that we had identified in previous [18 F] fluorodeoxyglucose/positron emission tomography studies. Following unilateral subthalamic nucleus ablation, a highly significant reduction in glucose utilization was present in the midbrain ipsilateral to the lesion site, most pronounced in the vicinity of the substantia nigra pars reticularis. Significant metabolic reductions were also present in the ipsilateral internal globus pallidus, ventral thalamus, and pons. Operative changes in Parkinson's disease network activity differed significantly for the lesioned and unlesioned hemispheres. In the lesioned hemisphere, network activity declined significantly following surgery, but was unaltered in the contralateral, unlesioned hemisphere. These results suggest that subthalamotomy reduces basal ganglia output through internal globus pallidus/substantia nigra pars reticularis and also influences downstream neural activity in the pons and ventral thalamus. This procedure also reduces the activity of abnormal Parkinson's disease‐related metabolic brain networks, suggesting a widespread modulation of motor circuitry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic topography of parkinsonism
Eidelberg, D., Moeller, J. R., Dhawan, V., Spetsieris, P., Takikawa, S., Ishikawa, T., Chaly, T., Robeson, W., Margouleff, D., Przedborski, S., et al. (1994) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1994.99 · Cited by 455 · cited 6×
“We have found this pattern of functional abnormality to be a consistent feature of PD patients scanned with FDG/PET.(26,27) We attribute the decline in pontine glucose metabolism subsequent to subthalamotomy to a reduction in the afferents to PPN from GPi and SNr, and possibly from the STN itself.”
BackgroundResultInfluentialSelf-citationOrganization of the nigrothalamocortical system in the rhesus monkey
Ilinsky, I. A., Jouandet, M. L., & Goldman‐Rakic, P. S. (1985) · Journal of Comparative Neurology · doi:10.1002/cne.902360304 · Cited by 406
Cited by
Kaplitt, M. G., Feigin, A., Tang, C., Fitzsimons, H. L., Mattis, P., Lawlor, P. A., Bland, R. J., Young, D., Strybing, K., Eidelberg, D., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60982-9 · Cited by 1,067
Self-citationUncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both
McIntyre, C. C., Savasta, M., Kerkerian-Le Goff, L., & Vitek, J. L. (2004) · Clinical Neurophysiology · doi:10.1016/j.clinph.2003.12.024 · Cited by 741
Network modulation in the treatment of Parkinson's disease
Asanuma, K. (2006) · Brain · doi:10.1093/brain/awl162 · Cited by 358
Subthalamic GAD Gene Therapy in a Parkinson's Disease Rat Model
Luo, J., Kaplitt, M. G., Fitzsimons, H. L., Zuzga, D. S., Liu, Y., Oshinsky, M. L., & During, M. J. (2002) · Science · doi:10.1126/science.1074549 · Cited by 325
Herholz, K. (2003) · Annals of Nuclear Medicine · doi:10.1007/bf02988444 · Cited by 217
Metadata
- Authors
- Su, P. C., Ma, Y., Fukuda, M., Mentis, M. J., Tseng, H., Yen, R., Liu, H., Moeller, J. R., & Eidelberg, D.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2001-10
- Volume
- 50
- Issue
- 4
- Pages
- 514-520
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2082662005
- Cited by
- 90
- References
- 2
- FWCI
- 5.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.